BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28805018)

  • 21. Sonographic joint assessment in rheumatoid arthritis: associations with clinical joint assessment during a state of remission.
    Gärtner M; Mandl P; Radner H; Supp G; Machold KP; Aletaha D; Smolen JS
    Arthritis Rheum; 2013 Aug; 65(8):2005-14. PubMed ID: 23686535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study.
    da Silva Chakr RM; Brenol JC; Behar M; Mendonça JA; Kohem CL; Monticielo OA; Brenol CV; Xavier RM
    PLoS One; 2015; 10(3):e0118620. PubMed ID: 25738587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
    Kaeley GS; Nishio MJ; Goyal JR; MacCarter DK; Wells AF; Chen S; Kupper H; Kalabic J
    Arthritis Rheumatol; 2016 Nov; 68(11):2584-2592. PubMed ID: 27214046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine Assessment of Patient Index Data 3 and the American College of Rheumatology/European League Against Rheumatism Provisional Remission Definitions as Predictors of Radiographic Outcome in a Rheumatoid Arthritis Clinical Trial With Tocilizumab.
    Khawaja MN; Bergman MJ; Yourish J; Pei J; Reiss W; Keystone E
    Arthritis Care Res (Hoboken); 2017 May; 69(5):609-615. PubMed ID: 27564431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gray Scale and Power Doppler Ultrasonographic Findings in the Assessment of Disease Activity and Their Correlation with Disease Activity Parameters in Rheumatoid Arthritis.
    Jindal S; Kaushik R; Raghuvanshi S; Kaushik RM; Kakkar R
    Curr Rheumatol Rev; 2018; 14(2):153-162. PubMed ID: 28117013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.
    Michelsen B; Kristianslund EK; Hammer HB; Fagerli KM; Lie E; Wierød A; Kalstad S; Rødevand E; Krøll F; Haugeberg G; Kvien TK
    Ann Rheum Dis; 2017 Apr; 76(4):708-711. PubMed ID: 27707730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between disease activity and patient-reported outcomes in rheumatoid arthritis: Post hoc analyses of overall and Japanese results from two phase 3 clinical trials.
    Ishiguro N; Dougados M; Cai Z; Zhu B; Ishida M; Sato M; Gaich C; Quebe A; Stoykov I; Tanaka Y
    Mod Rheumatol; 2018 Nov; 28(6):950-959. PubMed ID: 29278006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound-defined remission and active disease in rheumatoid arthritis: association with clinical and serologic parameters.
    Dejaco C; Duftner C; Wipfler-Freissmuth E; Weiss H; Graninger WB; Schirmer M
    Semin Arthritis Rheum; 2012 Jun; 41(6):761-7. PubMed ID: 22055540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
    Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
    Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High pain catastrophizing scores in one-fourth of patients on biotherapy for spondylarthritis or rheumatoid arthritis.
    Penhoat M; Saraux A; Le Goff B; Augereau P; Maugars Y; Berthelot JM
    Joint Bone Spine; 2014 May; 81(3):235-9. PubMed ID: 24321439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relation between composite ultrasound measures and the DAS28 score, its components and acute phase markers in adult RA.
    Hameed B; Pilcher J; Heron C; Kiely PD
    Rheumatology (Oxford); 2008 Apr; 47(4):476-80. PubMed ID: 18281367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Fatigue in Rheumatoid Arthritis Patients in Remission or in a Low Disease Activity State.
    Olsen CL; Lie E; Kvien TK; Zangi HA
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):1043-8. PubMed ID: 26555897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global assessments of disease activity are age-dependent determinant factors of clinical remission in rheumatoid arthritis.
    Ito H; Ogura T; Hirata A; Takenaka S; Mizushina K; Fujisawa Y; Katagiri T; Hayashi N; Kameda H
    Semin Arthritis Rheum; 2017 Dec; 47(3):310-314. PubMed ID: 28532573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes.
    Gul HL; Eugenio G; Rabin T; Burska A; Parmar R; Wu J; Ponchel F; Emery P
    Rheumatology (Oxford); 2020 Mar; 59(3):613-621. PubMed ID: 31424522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain and Self-reported Swollen Joints Are Main Drivers of Patient-reported Flares in Rheumatoid Arthritis: Results from a 12-month Observational Study.
    Kuettel D; Primdahl J; Weber U; Terslev L; Østergaard M; Petersen R; Pedersen AK; Möller S; Hørslev-Petersen K
    J Rheumatol; 2020 Sep; 47(9):1305-1313. PubMed ID: 31787604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.
    Hurnakova J; Zavada J; Hanova P; Hulejova H; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Komarc M; Vencovsky J; Pavelka K; Senolt L
    Arthritis Res Ther; 2015 Sep; 17(1):252. PubMed ID: 26373925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of large-joint ultrasonographic synovitis is delayed in patients with newly diagnosed rheumatoid arthritis: results of a 12-month clinical and ultrasonographic follow-up study of a local cohort.
    Harman H; Tekeoğlu İ; Takçı S; Kamanlı A; Nas K; Harman S
    Clin Rheumatol; 2015 Aug; 34(8):1367-74. PubMed ID: 25833144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study.
    Perrotta FM; De Socio A; Scriffignano S; Lubrano E
    Clin Rheumatol; 2018 Jun; 37(6):1449-1455. PubMed ID: 29468339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrasound7 versus ultrasound12 in monitoring the response to infliximab in patients with rheumatoid arthritis.
    Leng X; Xiao W; Xu Z; Zhu X; Liu Y; Zhao D; Xu H; Chen G; Yu W; Lu J; Wang J; Xia X; Li Y; Zhao Y; Tang H; Shi Y; Bao J; Chen L; Lin L; Zhou L; Zhang H; Zhao Y
    Clin Rheumatol; 2016 Mar; 35(3):587-94. PubMed ID: 26781785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain and Catastrophizing in Patients With Rheumatoid Arthritis: An Observational Cohort Study.
    Cohen EM; Edwards RR; Bingham CO; Phillips K; Bolster MB; Moreland LW; Neogi T; Marder W; Wohlfahrt A; Clauw D; Lee YC
    J Clin Rheumatol; 2019 Aug; 25(5):232-236. PubMed ID: 30035754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.